Pharmacy evidence record · researched 2026-08-20

Designer Drugs

The Wellness Center Pharmacy, Inc. dba Designer Drugs

5 citations2 action records6 explicit unknowns

Compounded with

Semaglutide

Not verified in the bound record.

Tirzepatide

Not verified in the bound record.

Product evidence does not establish current availability.

Locations in the source record

  • 7304 Jarnigan Road, Chattanooga, TN 37421

Services named by sources

  • 503A patient-specific compounding
  • Sterile and nonsterile compounding
  • Weight optimization
  • Hormone replacement
  • Dermatology
  • Sexual/mental health
  • Ophthalmic, injection, transdermal and veterinary formulations

Regulatory compliance

503 pathway evidence

A pathway label describes which federal rules apply — it is not a quality claim.

Section 503A

Source-backed pathway evidence

FDA's 2019 referral says the firm apparently obtained prescriptions for identified patients as required by section 503A.

Section 503B

Not conclusively established

not found in current fda registry check

Telehealth providers

No provider relationship is verified in the bound sources.

Clinic Scout links a provider only when an explicit source names the relationship.

Browse provider records

Regulatory history

Actions stay dated and bounded.

FDA warning/closeout, state-referral, Form 483/current-503B and Tennessee board sources were checked. The 2016 warning/2019 closeout and 2019 referral were verified; no later state order was recovered.

U.S. Food and Drug Administration · 2016-08-05

Warning Letter

FDA later stated that the firm appeared to have adequately addressed the violations in this warning letter.

closed_out_2019-02-06

U.S. Food and Drug Administration · 2019-02-06

State referral letter

After a December 2017 inspection, FDA referred poor sterile-practice concerns to Tennessee. FDA listed media-fill, contamination and cleaning concerns, stated that the deviations appeared readily correctable, and said FDA did not intend further action at that time regarding that inspection.

Status not stated

What remains unverified

No Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.

What this record verifies for you

6 evidence dimensions carry dated, source-backed verification.

Each line traces to a citation in the source list below — read the exact captured wording before relying on it.

No superiority claim is made for review volume, ratings, or patient sentiment.

Sources and exact captured wording

  1. first_party · accessed 2026-08-20
    Our specialities range from hormone replacement therapy, dermatologics, and weight loss to sexual health, mental health, vitamins, and hydration.
  2. fda · accessed 2026-08-20
    FDA has completed an evaluation of your firm’s corrective actions in response to our warning letter #2016-NOL-11 dated August 5, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
  3. fda · accessed 2026-08-20
    The purpose of this letter is to refer to the Tennessee State Board of Pharmacy (BOP) for appropriate follow up, the U.S. Food and Drug Administration’s (FDA) concerns about poor sterile practices observed during an FDA inspection at ... The Wellness Center Pharmacy, Inc., dba Designer Drugs
  4. fda · accessed 2026-08-20
    After review of the record, FDA does not intend to take further action at this time with regard to the findings of this inspection ... FDA is referring this matter to the Tennessee BOP for follow up to ensure appropriate corrective action is taken.
  5. fda · accessed 2026-08-20
    Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.

Questions readers ask

Is Designer Drugs legit?

GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 2 regulatory/action record(s), and 6 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.

Still have questions? Read the research library or email us at [email protected].